Lucentis

Genentech Ophthalmology Access Solutions Patient Guide: How to Get Lucentis (ranibizumab) at Low or No Cost

Lucentis (ranibizumab) is an injectable medication used to treat serious eye conditions like wet age-related macular degeneration (wAMD), diabetic macular edema, and retinal vein occlusion by blocking abnormal blood vessel growth in the eye.[1][9] The Genentech Ophthalmology Access Solutions program, run by Genentech, helps eligible patients access Lucentis through services like co-pay assistance, benefits investigations, and reimbursement support, making treatment more affordable regardless of income.[1][2][4]

Who Qualifies for the Program?

This program is designed for patients prescribed Genentech ophthalmology medicines like Lucentis who need help navigating insurance or affording out-of-pocket costs.[1][7] Eligibility is not based on income, a key benefit that opens the program to a wide range of people.[program details] You may qualify if you have commercial insurance, public insurance, or no insurance at all.[program details][4] However, patients enrolled in federal, state, or government-funded programs (like Medicare, Medicaid, VA, or Tricare) are not eligible.[program details][4]

The program offers multiple support options:

• Benefits Investigation (BI): Checks your insurance coverage, deductibles, and co-pays.[5][9]
• Prior Authorization (PA) Support: Helps your doctor submit paperwork for insurance approval.[5][9]
• Co-pay Program: Reduces out-of-pocket costs for commercially insured patients.[4][8]
• Reimbursement Support: Covers costs via payments to patients, pharmacies, physician offices, or hospitals.[program details]
• Appeals Assistance: Guidance (but not submission) if insurance denies coverage.[5][6]

About Lucentis (ranibizumab)

Lucentis is a prescription eye injection given by an ophthalmologist every 4-8 weeks, depending on your condition.[9] It targets vascular endothelial growth factor (VEGF), a protein that causes leaky blood vessels in the retina, which can lead to vision loss. Common uses include:

• Wet age-related macular degeneration (wAMD)
• Macular edema following retinal vein occlusion (RVO)
• Diabetic macular edema (DME)
• Myopic choroidal neovascularization (mCNV)

Treatment is typically administered in a doctor's office or clinic. Without assistance, costs can exceed $2,000 per dose, but this program helps bridge the gap.[1][9] Always discuss side effects like eye pain, floaters, or infection risk with your doctor.

Income Eligibility Breakdown

Unlike many programs, Genentech Ophthalmology Access Solutions does not use income thresholds. There are no limits based on Federal Poverty Level (FPL) or household size.[program details] This makes it accessible to working families, retirees, and others who might exceed typical program cutoffs.

Insurance Requirements

Eligible insurance types:

• Commercial/private insurance (e.g., employer plans, marketplace)
• Public insurance (specifics vary; confirm via phone)
• Uninsured (may qualify for Genentech Patient Foundation)[2][4]

Ineligible:

• Federal/state government programs (Medicare Part A/B/D, Medicaid, VA, etc.)[program details]

Your doctor completes a form noting your insurance details or confirming uninsured status.[4] The program performs a benefits investigation to clarify coverage.[1][5]

Step-by-Step Application Process

Applications use multiple methods—phone, fax, text, or online portal. Both Patient Consent Form and Prescriber Service Form are required before any action.[2][4][5]

1. Contact the Program: Call (866) 422-2377 or (833) EYE-GENE (833-393-4363) Monday-Friday, 9am-8pm ET. Discuss your needs and start enrollment.[1][4][9]

2. Complete Patient Consent Form: Download from Genentech-Access.com/Ophthalmology (English/Spanish). Sign and date it. This authorizes sharing your info.[2][3]

3. Doctor Completes Prescriber Service Form: Provide your doctor's office with patient details, diagnosis codes, insurance info (or uninsured note), and requested services (e.g., co-pay referral).[4]

4. Submit Forms:

   • Online: Use My Patient Solutions portal if registered.[2][5]
   • Fax: (866) 724-9412 or (833) 999-4363[2][4]
   • Text: Photo to 650-877-1111[2]
   • Phone: For guidance.[1]

5. Await Review: Processed in about 5 business days.[2] Your office gets contacted with outcomes.[2]

Reauthorization is required for ongoing treatment—your doctor resubmits periodically.[program details]

Timeline and Delivery

• Processing: 5 business days after receiving both forms.[2]
• Delivery: Reimbursement sent to patient, pharmacy, doctor's office, or hospital—not direct drug shipment.[program details]
• Co-pay Cards: Issued digitally or via mail for eligible commercial patients.[8]

Track status via My Patient Solutions or phone.[5]

Alternatives if Denied or Ineligible

• Appeals: Program provides sample letters and tips (you/your doctor submit).[5][9]
• Genentech Patient Foundation: For uninsured; separate enrollment.[2][4]
• Other Resources: NeedyMeds, RxAssist, or PAN Foundation for eye meds.
• Biosimilars: None currently listed.[program details]
• Free Samples: Ask your doctor.[9]

Important Disclaimer

This guide is for informational purposes only and based on publicly available program details as of 2026. Eligibility, benefits, and terms can change—always verify with Genentech at (866) 422-2377.[1] Not affiliated with Genentech. Consult your doctor for medical advice. Program excludes government insurance. Co-pay help may have annual caps. Genentech reserves rights to modify/terminate.[4][program details] (Word count: 1028)